...
首页> 外文期刊>International Medical Case Reports Journal >Early treatment failure in concurrent dengue and mixed malaria species infection with suspected resistance to artemisinin combination therapy from a tertiary care center in Delhi: a case report
【24h】

Early treatment failure in concurrent dengue and mixed malaria species infection with suspected resistance to artemisinin combination therapy from a tertiary care center in Delhi: a case report

机译:德里三级护理中心同时发生登革热和混合疟疾感染并怀疑对青蒿素联合治疗产生耐药性的早期治疗失败:一例病例报告

获取原文
           

摘要

Background: Concurrent dengue and mixed malaria infections in a single patient present with overlapping clinical manifestations which pose a diagnostic challenge and management dilemma in areas of common endemicities. Methods: We report a case of a young male who tested positive for both Plasmodium vivax and Plasmodium falciparum along with dengue infection. He showed signs of early treatment failure to artemisinin combination therapy (artesunate with sulfadoxine+pyrimethamine). Molecular analysis for the drug resistance genes viz: chloroquine resistance ( pfcrt ), multidrug resistance ( pfmdr-1 ), sulfadoxine ( pfdhps ), pyrimethamine ( pfdhfr ), and artemisinin resistance ( keltch 13 ) was performed. Results: A rise in parasitemia from <2% to 5% was observed after 3 days of treatment. Mutations?in pfcrt , pfmdr-1 , pfdhfr , and pfdhps genes were detected as a possible cause of treatment failure. Conclusion: Increased severity, overlapping symptoms, and suspected resistance to treatment warrants a multidimensional diagnostic approach and diligent therapeutic monitoring.
机译:背景:一名患者同时发生登革热和混合疟疾感染,临床表现重叠,这在常见流行地区构成了诊断挑战和管理难题。方法:我们报告了一例年轻男性男性,该患者的间日疟原虫和恶性疟原虫与登革热感染均呈阳性。他表现出青蒿素联合治疗(青蒿琥酯与磺胺多辛+乙胺嘧啶)早期治疗失败的迹象。进行了耐药基因的分子分析:氯喹耐药性(pfcrt),多药耐药性(pfmdr-1),磺胺多辛(pfdhps),乙胺嘧啶(pfdhfr)和青蒿素耐药性(keltch 13)。结果:治疗3天后,寄生虫血症从<2%上升到5%。检测到pfcrt,pfmdr-1,pfdhfr和pfdhps基因中的突变是治疗失败的可能原因。结论:严重性增加,症状重叠以及怀疑对治疗的抵抗力值得采用多维诊断方法和认真的治疗监测。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号